Trial results suggest people with newly diagnosed glioblastoma could potentially be given extra years of life
The world’s first vaccine to treat deadly cancerous brain tumours can potentially give patients years of extra life, a global clinical trial has concluded.
A senior NHS doctor who was one of the trial’s chief investigators said the evidence showed DCVax had resulted in “astonishing” enhanced survival for patients.
